Smad4 (DPC4) - a potent tumour suppressor?
1998

The Role of Smad4 in Cancer

publication Evidence: moderate

Author Information

Author(s): EK Duff, AR Clarke

Primary Institution: The University of Edinburgh Medical School

Hypothesis

Is Smad4 a potent tumor suppressor in human cancers?

Conclusion

Loss of Smad4 is primarily associated with pancreatic cancer and to a lesser extent with colorectal cancer.

Supporting Evidence

  • Smad4 loss is found in 27% of pancreatic cancers.
  • Smad4 mutations are linked to colorectal cancer.
  • Smad4 is essential for TGF-beta signaling and mammalian development.

Takeaway

Smad4 is a gene that helps prevent cancer, and when it doesn't work, it can lead to serious diseases like pancreatic cancer.

Methodology

Review of literature on Smad4's role in cancer.

Limitations

The evidence for Smad4's role in cancers other than pancreatic and colorectal is limited.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication